Goto

Collaborating Authors

BrainChip Simplifies Deep Learning with Launch of MetaTF

#artificialintelligence

WIRE)--BrainChip Holdings Ltd. (ASX: BRN), a leading provider of ultra-low power, high-performance AI technology, introduced MetaTF, a versatile ML framework that allows people working in the convolutional neural network space to quickly and easily move to neuromorphic computing without having to learn anything new, today at Linley Spring Conference 2021. The MetaTF development environment is an easy-to-use, complete machine learning framework for the creation, training and testing of neural networks, supporting the development of systems for Edge AI on BrainChip's Akida event domain neural processor. The MetaTF development environment leverages TensorFlow and Keras for industry-standard neural network development and training and includes the Akida Execution Engine (chip simulator), data-to-event converters, and a model zoo of pre-trained models. The framework leverages the Python scripting language and its associated tools and libraries, including Jupyter notebooks and NumPy. Deep-learning professionals do not need to learn a new framework to start using MetaTF immediately.


Innovative AI Breath Analyzer Diagnoses Diseases by "Smell"

#artificialintelligence

Imagine being able to know if you have Parkinson's disease, multiple sclerosis, liver failure, Crohn's diseases, pulmonary hypertension, chronic kidney disease, or any number of cancers based on a simple, non-invasive test of your breath. Breath analyzers to detect alcohol have been around for well over half a century--why not apply the same concept to detect diseases? A global team of scientists from universities in Israel, France, Latvia, China and the United States have developed an artificial intelligence (AI) system to detect 17 diseases from exhaled breath with 86 percent accuracy. The research team led by Professor Hassam Haick of the Technion-Israel Institute of Technology collected breath samples from 1404 subjects with either no disease (healthy control) or one of 17 different diseases. The disease conditions include lung cancer, colorectal cancer, head and neck cancer, ovarian cancer, bladder cancer, prostate cancer, kidney cancer, gastric cancer, Crohn's disease, ulcerative colitis, irritable bowel syndrome, idiopathic Parkinson's, atypical Parkinson ISM, multiple sclerosis, pulmonary hypertension, pre-eclampsia toxemia, and chronic kidney disease.


BrainChip Simplifies Deep Learning with Launch of MetaTF

#artificialintelligence

April 22, 2021--BrainChip Holdings Ltd. (ASX: BRN), a leading provider of ultra-low power, high-performance AI technology, introduced MetaTF, a versatile ML framework that allows people working in the convolutional neural network space to quickly and easily move to neuromorphic computing without having to learn anything new, today at Linley Spring Conference 2021. The MetaTF development environment is an easy-to-use, complete machine learning framework for the creation, training and testing of neural networks, supporting the development of systems for Edge AI on BrainChip's Akida event domain neural processor. The MetaTF development environment leverages TensorFlow and Keras for industry-standard neural network development and training and includes the Akida Execution Engine (chip simulator), data-to-event converters, and a model zoo of pre-trained models. The framework leverages the Python scripting language and its associated tools and libraries, including Jupyter notebooks and NumPy. Deep-learning professionals do not need to learn a new framework to start using MetaTF immediately.


BrainChip Introduces Energy Efficient and Precise AI Edge Solution at AI Field Day - Gestalt IT

#artificialintelligence

Artificial Intelligence (AI) is a rapidly growing field. In "The State of AI in 2020" report, McKinsey found that 50% of the organizations surveyed have adopted AI in at least one function within their business. BrainChip developed the Akida Event-Domain Neural Processor to enable AI to run at an organization's edge, a location AI typically couldn't reach. BrainChip introduced and demonstrated the Akida solution at AI Field Day in November. The typical AI system requires thousands of data points to successfully train the algorithm and a powerful system to process the model.


BrainChip Showcases Vision and Learning Capabilities of its Akida Neural Processing IP and Device at tinyML Summit 2020

#artificialintelligence

BrainChip Holdings Ltd. (ASX: BRN), a leading provider of ultra-low power, high-performance edge AI technology, today announced that it will present its revolutionary new breed of neuromorphic processing IP and Device in two sessions at the tinyML Summit at the Samsung Strategy & Innovation Center in San Jose, California February 12-13. In the Poster Session, "Bio-Inspired Edge Learning on the Akida Event-Based Neural Processor," representatives from BrainChip will explain to attendees how the company's Akida Neuromorphic System-on-Chip processes standard vision CNNs using industry standard flows and distinguishes itself from traditional deep-learning accelerators through key features of design choices and bio-inspired learning algorithm. These features allow Akida to require 40 to 60 percent fewer computations to process a given CNN when compared to a DLA, as well as allowing it to perform learning directly on the chip. BrainChip will also demonstrate "On-Chip Learning with Akida" in a presentation by Senior Field Applications Engineer Chris Anastasi. The demonstration will involve capturing a few hand gestures and hand positions from the audience using a Dynamic Vision Sensor camera and performing live learning and classification using the Akida neuromorphic platform.